Your choice affects onset time, bioavailability, and practical convenience
Known risks and important uncertainties BPC-157 does not have an approved product label defining contraindications, interactions, manufacturing specifications or a validated safety profile
The authors of one trial (95) included in the above-mentioned meta-analysis (89) noted that little cognitive decline was observed in the placebo group over their two-year trial, which may have limited their power to detect an effect of the B-vitamin intervention (95)
Mistake #5: Freezing the Reconstituted Solution
The most common finding is elevated liver enzyme levels (cholestatic, mixed and hepatocellular)
DAI may be an accompanying feature of mTBI (Maruta et al, 2010)